haloperidol - CISMeF

Preferred Label : haloperidol;

MeSH definition : A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279);

MeSH hyponym : haldol;

MeSH CAS label : 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-;

MeSH Related Number : 52-86-8 (Haloperidol);

Registry Number MeSH : 52-86-8;

Wikipedia link : https://en.wikipedia.org/wiki/Haloperidol;

Codes EINECS : 200-155-6;

Is substance : O;

UNII : J6292F8L3D;

InChIKey : LNEPOXFFQSENCJ-UHFFFAOYSA-N;

Details

Origin ID

D006220;

UMLS CUI

C0018546;

ATC code(s)
- haloperidol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Haloperidol adverse reaction (disorder) [SNOMED CT concept]
- Haloperidol measurement (procedure) [SNOMED CT concept]
- Poisoning caused by haloperidol (disorder) [SNOMED CT concept]
- haloperidol [Substance BNPC]
Currated CISMeF NLP mapping
- Haloperidol [ICD-11 Extension code]
- Haloperidol [LOINC component]
- Haloperidol [ICHI extension code]
- Haloperidol [SMS substance]
- Haloperidol [NCIt concept]
- Haloperidol (substance) [SNOMED CT concept]
- haloperidol [SNOMED Notion]
Pharmacological action(s)
- anti-dyskinesia agents [MeSH Descriptor]
- antiemetics [MeSH Descriptor]
- antipsychotic agents [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
- dopamine antagonists [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
- psychotropic drugs [MeSH Descriptor]
Record concept(s)
- haldol [MeSH concept]
- haloperidol [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine [MeSH Supplementary Concept]
- 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine [MeSH Supplementary Concept]
- 4-(4-(4-chlorophenyl)-1,4-diazepan-1-yl)-1-(4-fluorophenyl)butan-1-one [MeSH Supplementary Concept]
- 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol [MeSH Supplementary Concept]
- 4-(4-(4-chlorophenyl)-4-hydroxyazepan-1-yl)-1-(4-fluorophenyl)butan-1-one [MeSH Supplementary Concept]
- 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butyl 4-phenylbutyrate [MeSH Supplementary Concept]
- 4-(4-chlorophenyl)-1-(4-(4-fluoro-phenyl))-4-hydroxybutylpyridinium [MeSH Supplementary Concept]
- 4-phenyl-1-(4-phenylbutyl)piperidine [MeSH Supplementary Concept]
- N-(4'-fluorobutyrophenone)-4-(4-chlorophenyl)pyridinium [MeSH Supplementary Concept]
- N-(4-tert-butylbenzyl)haloperidol [MeSH Supplementary Concept]
- N-n-butyl haloperidol iodide [MeSH Supplementary Concept]
- bromperidol [MeSH Supplementary Concept]
- bromperidol decanoate [MeSH Supplementary Concept]
- buzepide metiodide, haloperidol drug combination [MeSH Supplementary Concept]
- dihydrohaloperidol [MeSH Supplementary Concept]
- haloperidol 4-azidobenzoate [MeSH Supplementary Concept]
- haloperidol decanoate [MeSH Supplementary Concept]
- haloperidol hemisuccinate [MeSH Supplementary Concept]
- haloperidol-succinylglycyliodotyrosine [MeSH Supplementary Concept]
- iodoperidol [MeSH Supplementary Concept]
- metoclophen [MeSH Supplementary Concept]
- metoclophen-modified nausea suppository [MeSH Supplementary Concept]
- sila-haloperidol [MeSH Supplementary Concept]
- thioketal haloperidol [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Haloperidol Measurement [NCIt concept]
- Product containing haloperidol (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Haloperidol [ICD-11 Extension code]
- Haloperidol [NCIt concept]
- Haloperidol [LOINC component]
- Haloperidol (substance) [SNOMED CT concept]
- Product containing haloperidol (medicinal product) [SNOMED CT concept]
- haloperidol [ATC Code]
- haloperidol [Substance BNPC]
- haloperidol [SNOMED Notion]
Validated automatic mappings to BTNT
- haloperidol [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients